Renal function and healthcare costs in patients with polycystic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 8, 2010, Pages 1471-1479

  Lentine, Krista L ^a   Xiao, Huiling ^a   Machnicki, Gerardo ^b   Gheorghian, Adrian ^a   Schnitzler, Mark A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Global Health Economics and Outcomes Research   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; BILLING AND CLAIMS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ECONOMIC EVALUATION; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE;

ADULT; AMBULATORY CARE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CREATININE; DRUG COSTS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; KIDNEY; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, ECONOMIC; NONLINEAR DYNAMICS; POLYCYSTIC KIDNEY DISEASES; PRIVATE SECTOR; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 77955729220     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00780110     Document Type: Article

References (32)

1. Grantham J, Cowley BJ, Torres VE: Progression of autosomal dominant polycystic kidney disease (ADPKD) to renal failure. In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW, Geibisch G, Philadelphia, Lippincott Williams and Wilkins, 2000, pp 2513-2536
2. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Jr., Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP: Volume progression in polycystic kidney disease. N Engl J Med 354: 2122-2130, 2006
3. Mitcheson H, Williams G, Castro JE: Clinical aspects of polycystic disease of the kidneys. BMJ 1: 1196-1199, 1977
4. Bear JC, McManamon P, Morgan J, Payne RH, Lewis H, Gault MH, Churchill DN: Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: Data for genetic counselling. Am J Med Genet 18: 45-53, 1984
5. Churchill DN, Bear JC, Morgan J, Payne RH, McManamon PJ, Gault MH: Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int 26: 190-193, 1984
6. Fick GM, Gabow PA: Natural history of autosomal dominant polycystic kidney disease. Annu Rev Med 45: 23-29, 1994
7. Incidence and prevalence of ESRD. United States Renal Data System. Am J Kidney Dis 32: S38-S49, 1998
8. Calvert JP: Strategies to inhibit cyst formation in ADPKD. Clin J Am Soc Nephrol 3: 1205-1211, 2008
9. Leuenroth SJ, Crews CM: Targeting cyst initiation in ADPKD. J Am Soc Nephrol 20: 1-3, 2009
10. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
11. Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB: Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 15: 1300-1306, 2004 (Pubitemid 38526011)
12. Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS: Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med 122: 443-453, 2009
13. Levey AS, Greene T, Kusek JW, Beck G: A simplified equation to prediction glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11: 155A, 2000
14. Smellie WS, Shaw N, Bowley R, Stewart MF, Kelly AM, Twomey PJ, Chadwick PR, Houghton JB, Ng JP, McCulloch AJ: Best practice in primary care pathology: Review 10. J Clin Pathol 60: 1195-1204, 2007 (Pubitemid 350084538)
15. Middleton RJ, Foley RN, Hegarty J, Cheung CM, McElduff P, Gibson JM, Kalra PA, O'Donoghue DJ, New JP: The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 21: 88-92, 2006 (Pubitemid 43057115)
16. Philipneri MD, Rocca Rey LA, Schnitzler MA, Abbott KC, Brennan DC, Takemoto SK, Buchanan PM, Burroughs TE, Willoughby LM, Lentine KL: Delivery patterns of recommended chronic kidney disease care in clinical practice: Administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 12: 41-52, 2008
17. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
18. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14: 270-277, 1999
19. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178-185, 2003
20. Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS: Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 16: 2439-2448, 2005
21. U.S. Renal Data System: USRDS 2008 Annual Data Report, Methods Appendix. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008. Available at http://www.usrds.org/2008/pdf/ V2-Appendices-2008.pdf. Accessed July 6, 2009
22. Lentine KL, Schnitzler MA, Abbott KC, Bramesfeld K, Buchanan PM, Brennan DC: Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol 4: 1213-1221, 2009
23. Bureau of Labor Statistics. Consumer Price Index, U.S. Average Medical Care. Available at http://data.bls.gov/PDQ/servlet/SurveyOutputServlet. Accessed August 7, 2009
24. London R, Solis A, Goldberg GA, Wade S, Ryu S: Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis 40: 539-548, 2002
25. St Peter WL, Khan SS, Ebben JP, Pereira BJ, Collins AJ: Chronic kidney disease: The distribution of health care dollars. Kidney Int 66: 313-321, 2004
26. Robbins JD, Kim JJ, Zdon G, Chan WW, Jones J: Resource use and patient care associated with chronic kidney disease in a managed care setting. J Manag Care Pharm 9: 238-247, 2003
27. Mensah GA, Brown DW: An overview of cardiovascular disease burden in the United States. Health Aff (Millwood) 26: 38-48, 2007
28. National Diabetes Statistics, 2007. Estimated Diabetes Costs in the United States in 2007. Available at http://diabetes.niddk.nih.gov/DM/PUBS/ statistics/#costs. Accessed August 7, 2009
29. Freedman BI, Soucie JM, Chapman A, Krisher J, McClellan WM: Racial variation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 35: 35-39, 2000
30. Perrone RD, Kausz TA, Chavers BM, Weinhandl ED, Collins AJ: Incidence of autosomal dominant polycystic kidney disease (ADPKD) among ESRD patients in the United States. J Am Soc Nephrol 16 (Suppl): 358A, 2005
31. DeNavas-Walt C, Proctor BD, Smith JC: Income, poverty, and health insurance coverage in the United States: 2007. Current Population Reports, US Census Bureau Issued 2008
32. Health Care Financing Administration. Prospective Payment System: Standardizing File. Washington DC, Department of Health and Human Services, 1998